Dr. Maya Guglin presented data that shows adding beta blockers or ACE inhibitors to a chemotherapy regimen for patients with HER2-positive breast cancer significantly reduces cardiotoxicity.
For the past four years, two junior faculty at UK have organized a symposium where outstanding scientists from UK and beyond present new scientific advances in women's heart health and explore translational cardiovascular research areas that merit further study.
Led by a multidisciplinary team of clinicians and scientists, the studies aim to develop new treatments using existing therapies that protect brain tissue after a stroke, and to learn more about the physiology of the event.
Over 350 researchers, students and guests attended the 20th UK Cardiovascular Research Day at the Lexington Convention Center, an annual event that celebrates the innovative research in cardiovascular health.
In a prime example of the unique type of cross-collaboration that takes place at academic medical centers, Markey's stem cell lab is working together with the Kentucky Neuroscience Institute to bring an innovative stroke clinical trial to UK HealthCare.
Testing and targeting treatment on a patient's virtual heart could lead to longer and healthier lives, especially for the 5.7 million adults with heart failure. Two UK researchers are working to make this a reality.
